SCHEMBL21774366

SCHEMBL21774366

Cc1cc(OCNC(=O)C(C)C)n(-c2ccccc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
L3MBTL1 Q9Y468 2/20 0.47
ATM Q13315 1/20 0.47
NTRK1 P04629 4/20 0.47
P2RY1 P47900 1/20 0.46
GAA P10253 1/20 0.44
MDM2 Q00987 1/20 0.44
SCN9A Q15858 1/20 0.44
MAPT P10636 3/20 0.43
TSHR P16473 1/20 0.43
KCNJ6 P48051 1/20 0.43
KCNJ5 P48544 1/20 0.43
KCNJ3 P48549 1/20 0.43
LMNA P02545 1/20 0.43
STAT1 P42224 1/20 0.43
HTT P42858 1/20 0.43
KDM5A P29375 1/20 0.42
KDM4C Q9H3R0 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21774134 0.86 NTRK1 (0.50) ALDH1A1L3MBTL1ATMNTRK1P2RY1
SCHEMBL21753650 0.84 GAA (0.57) ALDH1A1L3MBTL1ATMNTRK1GAA
SCHEMBL21774357 0.84 ALDH1A1 (0.51) ALDH1A1L3MBTL1ATMNTRK1P2RY1
SCHEMBL30076258 0.83 ALDH1A1 (0.46) ALDH1A1L3MBTL1ATMNTRK1P2RY1
SCHEMBL21774351 0.83 ALDH1A1 (0.47) ALDH1A1L3MBTL1ATMNTRK1P2RY1
SCHEMBL21774129 0.82 ALDH1A1 (0.49) ALDH1A1L3MBTL1ATMNTRK1GAA
SCHEMBL21774299 0.81 ALDH1A1 (0.49) ALDH1A1L3MBTL1ATMNTRK1P2RY1
SCHEMBL21753629 0.81 P2RY1 (0.51) ALDH1A1L3MBTL1ATMNTRK1P2RY1
SCHEMBL21774368 0.81 ALDH1A1 (0.46) ALDH1A1L3MBTL1ATMNTRK1P2RY1
SCHEMBL28361285 0.80 LMNA (0.56) ALDH1A1L3MBTL1ATMNTRK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11692004-B2 Substituted pyrazole compound, preparation method therefor, pharmaceutical composition and medical use thereof JIANGSU VANGUARD PHARMACEUTICAL CO., LTD. (CN) 2023-07-04 US disclosed
US-11692004-B2 Substituted pyrazole compound, preparation method therefor, pharmaceutical composition and medical use thereof JIANGSU VANGUARD PHARMACEUTICAL CO., LTD. (CN) 2023-07-04 US disclosed
WO-2020038279-A1 SUBSTITUTED PYRAZOLE COMPOUND, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND USE THEREOF 天津谷堆生物医药科技有限公司 2020-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11692004-B2 Substituted pyrazole compound, preparation method therefor, pharmaceutical composition and medical use thereof FARS2, GOT2, HADHB ALDH1A1 2197/4885L3MBTL1 1066/4885ATM 2497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.